BNET Industries
Last Fiscal Year Sales:$250.5K
- Private
- US
Dow Jones Description
High quality sampling supplies, most competitive prices, exceptional service. We are striving to become the most reliable source for the environmental and geotechnical industries.
Owner
Larry ZhangNumber of Employees 7
Contact Information
14146 Firestone Blvd
Santa Fe Springs, California 90670
1 562 802 7010
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
cel-sci corp. and vfc's stock house - All News and Analysis
Holiday Cheer: Cel-Sci Should Have Good News
VFC submits: Shares of Cel Sci Corp. CVM continued to hover right around the $1.30 mark even after TheStreet.com's infamous biotech blogger thrust his most recent blogging salvo at Cel Sci in an attempt to keep his ongoing vendetta against the company alive - for reasons that are still...
Playing the Options Game in RIM; Cel Sci Not Yet Trading to Its Potential
VFC submits: In "Readers Respond" I do my best to answer readers' questions, but keep in mind that my responses to these questions are my opinions and personal speculation that I have based on my own research and due diligence. Also, I will try to respond to a...
Don't Like Celsius Holdings? Try Cel-Sci Instead
VFC submits: A comment from Scott regarding Celsius Holdings (CSUH.OB): You tell a nice warm story about Carl being the big dog and you waiting under the table at dinner time, but the numbers and profitablity win in the end. And you're brushing off the basic financial landscape....
Cel-Sci: Good News Could Lead to Long-Term Growth
VFC submits: As shares of Cel-Sci Corp. CVM have traded to the upside of late, the company is set to gain more exposure when it presents at the "7th Annual Vaccines: All Things Considered Conference" in Washington, DC on Tuesday afternoon. While I don't expect the Cel-Sci stock to...
Cel-Sci, Johns Hopkins Move Forward With LEAPS
VFC submits: Shortly after the market open on Friday, Cel-Sci Corp. CVM issued a press release declaring that the company will commence a Clinical Study measuring the effectiveness of the company's LEAPS technology in the treatment of H1N1-hospitalized patients. According to the press release, blood will be drawn from...
Cel Sci's Targets Stay on Track
VFC submits: Last week I had the opportunity to visit Cel Sci's CVM new, state of the art Multikine production facility near Baltimore, MD. During the visit, I was given a tour of the interior by Dr. Eyal Talor and Mr. W. Brooke Jones of Cel Sci Corp. Upon...
Cel-Sci: Things Are Just Getting Started
VFC submits: CVM: Shares of Cel Sci traded with continued volatility on Monday, after the company announced positive results for CEL-2000 (based on the company's LEAPS technology) in the treatment of Rheumatoid arthritis at the American College of Rheumatology Conference in Philadelphia on Sunday. It was also noted...
Cel-Sci: Why I'm Buying if the Price Dips
VFC submits: In "Readers Respond" I do my best to answer readers' questions, but keep in mind that these questions are my opinions and personal speculation that I have based on my own research and due diligence (DD). I don't invent the facts that are based in publicly available...
Cel Sci: Job Listings Are a Good Sign
VFC submits: What's left to say about Cel Sci Corp. CVM? That company and its stock have received a heck of a lot of press over the past couple of weeks and I maintain my opinion that - in my opinion - the stock will pay off based on...
Remaining Grounded Through the Unethical Attacks on Cel Sci
VFC submits: [Update below] Shares of Cel Sci Corp CVM were on the rebound during early trading on Wednesday after the effects of some unfounded attacks on the company by Adam Feuerstein and The Street.com look to have finally wore off. by VFC's Stock House
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Larry Zhang | Owner |
| Organization | Position | Status |
|---|---|---|
| Cel Scientific Corporation | Owner | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes


